Gentherm (THRM) Q2 2026 Earnings Call Transcript
Gentherm held its Q2 2026 earnings call on July 23, 2026, reporting strong commercial execution and operational discipline that led to an excellent first half. The company raised its full-year 2026 guidance. Key highlights include: Gentherm products were selected by two leading North American furniture brands for the home and office market, with visibility to $50-$100 million in revenue by 2028. In the medical market, the company received FDA 510(k) clearance for ThermAffyx, an innovative solution leveraging automotive technology. The company continues to outperform the automotive market and is proactively managing inflationary pressures through disciplined commercial actions. Management emphasized strategic profitable growth and momentum beyond the light vehicle market.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page itself is projected from evidence records.
- Current automated evidence projection